Across TCGA pan-cancer cohorts, CCDC167 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of CCDC167’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where CCDC167 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types CCDC167 is over-expressed in tumor.

LSCC and COAD are the cancer types where CCDC167 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CCDC167 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	Male	III,IV	+1.183	<.001	8	view →
COAD	All	All	+0.405	.002	7	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: CCDC167 RNA expression & survival · all CCDC167 data types